By: Max R. Wursta
Results showed patients with a BMI of 40 kg/m2 or more who used glucagon-like peptide-1 receptor agonists for at least 90 days before and after total knee arthroplasty had a decreased risk for postoperative complications vs. controls. Billy I. Kim, MD, orthopedic surgery resident in the department of orthopedic surgery at Hospital for Special Surgery, and colleagues performed a study of data